Policy · Tariff change · In force
Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients
U.S. Bureau of Industry and Security: Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclam.
United StatesUnited KingdomPharmaceuticals
Why it matters
This is an announced measure. Recalculate landed cost only after the official text states scope and an effective date.
Who should watch
- Importers and pricing teams for the covered goods
What to do now
- Confirm product scope and effective date in the official text.
- Estimate landed cost only after that confirmation.
Official source
U.S. Bureau of Industry and Security · 4 Aug 2026 · Official source
Related developments
- Guidance and Procedures for Implementing Tariff Adjustments for Specialty Pharmaceuticals · 23 Sep 2026
- USTR holds hearing on Germany pharmaceutical Section 301 investigation · 21 Sep 2026
- United Kingdom updates import compliance and customs declaration requirements · 28 May 2026
- Big win for Scotch whisky as US tariffs are lifted · 24 Jul 2026
More detail
Business impact
| Country | Industry | Level | Note |
|---|---|---|---|
| United States | Cross-border Trade | Medium | This is an announcement or process update, not an implemented duty rate. Do not treat an unstated ra |
| United Kingdom | Cross-border Trade | Low | — |
Background
Why It Matters Duty treatment covered by “Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kin” may change landed-cost assumptions for United States, United Kingdom; recalculate only after confirming scope and effective date in the official text.
What To Check Confirm product scope and effective date in the official text before repricing.
Follow affected entities